CAS 2440087-54-5

Fórmula: C38H48N4O9

InChI: InChI=1S/C38H48N4O9/c1-23(2)21-50-33-18-26(36(44)39-29-11-6-25(5)7-12-29)8-13-30(33)40-37(45)27-9-14-31(34(19-27)51-22-24(3)4)41-38(46)28-10-15-32(42(47)48)35(20-28)49-17-16-43/h8-10,13-15,18-20,23-25,29,43H,6-7,11-12,16-17,21-22H2,1-5H3,(H,39,44)(H,40,45)(H,41,46)

Chave InChI: QOYORXKDWMJNHD-UHFFFAOYSA-N

SMILES: CC1CCC(CC1)NC(=O)C2=CC(=C(C=C2)NC(=O)C3=CC(=C(C=C3)NC(=O)C4=CC(=C(C=C4)[N+](=O)[O-])OCCO)OCC(C)C)OCC(C)C

ERX-41

CAS: 2440087-54-5

ERX-41

Fórmula: C₃₈H₄₈N₄O₉

Pureza: 99%

Peso molecular: 704.81

Ref: 54-OR1103971

ERX-41

CAS: 2440087-54-5

Fórmula: C₃₈H₄₈N₄O₉

Pureza: 99%

Peso molecular: 704.8091

Ref: IN-DA027SG2

ERX-41

CAS: 2440087-54-5

ERX-41 is an orally active, stereospecific small molecule that targets lysosomal acid lipase A (LIPA).

Fórmula: C₃₈H₄₈N₄O₉

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 704.81

Ref: TM-T78528